Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Glutamine - Emmaus Medical

Next Previous
X
Search
Drug Profile

Glutamine - Emmaus Medical

Alternative Names: ELS-001; ELS-004; ELS-007; Endari; L-glutamine - Emmaus Medical; L-glutamine oral powder - Emmaus Medical; Levoglutamide; NutreStore; PGLG - Emmaus Medical; SCD therapy; Xyndari

Latest Information Update: 28 May 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Nutritional Restart Pharmaceutical
  • Developer Emmaus Medical; myTomorrows; Nutritional Restart Pharmaceutical
  • Class Anti-inflammatories; Antianaemics; Antihyperglycaemics; Basic amino acids; Diamino amino acids; Neutral amino acids; Small molecules
  • Mechanism of Action Antioxidants; Protein synthesis modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Sickle cell anaemia; Short bowel syndrome
  • New Molecular Entity No
  • Available For Licensing Yes - Diverticulitis; Sickle cell anaemia

Highest Development Phases

  • Marketed Short bowel syndrome; Sickle cell anaemia
  • Phase III Thalassaemia
  • Phase II Diverticulitis
  • No development reported Pancreatic cancer; Type 2 diabetes mellitus

Most Recent Events

  • 28 May 2024 No recent reports of development identified for phase-I development in Pancreatic-cancer(Combination therapy, First-line therapy, Late-stage disease) in USA (PO, Powder)
  • 02 Feb 2024 Registered for Sickle cell anaemia (In adults, In children, In adolescents) in Puerto Rico (PO)
  • 13 Jul 2023 Emmaus Life Sciences plans to launch L-glutamine in Oman

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top